UPDATE: BofA Securities Double Downgrades Ionis Pharmaceuticals (IONS) to Underperform
Tweet Send to a Friend
(Updated - February 1, 2022 7:20 AM EST)
BofA Securities analyst Jason Gerberry downgraded Ionis Pharmaceuticals (NASDAQ: IONS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Gerberry downgraded Ionis Pharmaceuticals (NASDAQ: IONS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
